Baxter Ventures
VC Fund
Deerfield, United States
Baxter Ventures is a VC fund in Deerfield focused on Health Care and Biotechnology. Baxter Ventures invests in companies with innovative technologies, products and therapies with the ability to improve patient care globally and maximize value for investors and entrepreneurs. Our focus includes therapeutic areas complementary to those of Baxter's Medical Products and BioScience businesses, as well as cutting-edge technologiesand therapies outside of our current product portfolio that have sustainable long-term growth potential.As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to develop products and therapies that advance patient care worldwide.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 42%
Last updated:
For AI agents: llms.txt
Industries Baxter Ventures invests in
Stages Baxter Ventures invests in
Countries Baxter Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anne Sissel
|
|||
4 more contacts available
Investment Focus
Industry
- Health Care 14 (74%)
- Biotechnology 11 (58%)
- Therapeutics 6 (32%)
- Medical 5 (26%)
- Medical Device 5 (26%)
Stage
- Series C 8 (42%)
- Series A 3 (16%)
- Series B 3 (16%)
- Series D 2 (11%)
- Funding Round 2 (11%)
Country
- United States 13 (68%)
- India 1 (5%)
- Spain 1 (5%)
- Israel 1 (5%)
- Iceland 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Anne Sissel
Vice President, Strategic Initiatives Advanced Surgery
|
Vice President, Strategic Initiatives Advanced Surgery | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hospital IQ
|
Hospital IQ is the leading predictive analytics platform applying proven operations research to improve hospital operational efficiency and patient quality through smarter data-driven decision making. The company works with a number of leading institutions including Brigham and Women’s Hospital to systematically optimize capacity, schedules, andstaffing. Hospital IQ’s automated reporting, modeling, and prediction tools are used to improve utilization and throughput across a hospital or hospital network.Hospital IQ was founded by a veteran team of operations management and software engineers, in consultation with leading industry experts, driven by a mission to apply operations research principles to improve hospital efficiency. | $25M / Series C / Jun 28, 2021 | |
Alvotech
|
Alvotech is a fully integrated specialty biopharmaceutical company focused exclusively on the development and manufacture of high-quality biosimilar medicines. The company has seven key products in development and a new state-of-the-art manufacturing plant for development and manufacture in Reykjavík, Iceland. | $65M / Oct 27, 2020 | |
Medasense
|
Medasense (www.medasense.com) offers a breakthrough technology that enables clinicians to optimize and personalize pain control and avoid overmedicationMedasense’s flagship product, the PMD-200 with its NOL® index, is a unique platform that objectively monitors and quantifies the patient’s pain response by means of artificial intelligence and aproprietary non-invasive sensor platform. The PMD-200 is used to optimize pain management in operating rooms and critical care settings, where patients are unable to communicate – a $5B market. The company’s pipeline cloud-based solutions for clinics and home, leveraging the NOL technology, addresses an additional $15B global market.The PMD-200 is distributed in Europe exclusively by Medtronic (NYSE:MDT), is cleared for marketing also in Canada, Latin America and Australia, and enables connectivity with Philips patient monitors. Clinical studies have demonstrated its impact on patient safety and outcomes, including opioid-sparing.Medasense was founded in 2008 and based in Ramat Gan, Tel Aviv, Israel. | $18M / Series C / Sep 22, 2020 | |
Prescient Surgical
|
Prescient Surgical, Inc. engages in the development of medical devices for the prevention of surgical site infection. The company offers Cleancision that prevents dangerous surgical wound infections. It provides products primarily for patients undergoing high-risk abdominal gastrointestinal surgery. The company was incorporated in 2012 and is basedin Mountain View, California. | $10M / Series B / Nov 28, 2018 | |
Outset Medical
|
Outset Medical is a pioneering medical technology company that manufactures medical equipment. The company reimagining dialysis for patients and health care providers. The innovative, compact, user-friendly Tablo Hemodialysis System can deliver both acute and chronic dialysis, wherever you need it.Through the versatile, all-in-one TabloHemodialysis System, they are using innovative technology to drive service model innovation, aimed at reducing cost and transforming the patient care experience. The system comes equipped with wireless data, sensor-based automation, and an animated touchscreen to make the system as easy to use as possible. | $132M / Series D / Aug 28, 2018 | |
VitalConnect
|
VitalConnect develops wearable biosensor technology designed for wireless patient monitoring. It leverages extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms. The company's products are designed for inpatient and outpatientsettings, such as hospital monitoring, post-discharge care, cardiac monitoring, and pharmaceutical solutions. | $38M / Series C / Oct 31, 2017 | |
BUGWORKS Research
|
BUGWORKS is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR). The company was founded in 2014 and is based in Bangalore, India. | Jul 24, 2017 | |
Kit Check
|
KitCheck is a provider of a cloud software platform used to offer automated hospital pharmacy kit processing and medication tracking. The company provides cloud-hosted software combined with IoT technology to reduce kit replenishment time by 72-96% while simultaneously delivering higher accuracy and eliminating errors. In addition, the Narc Checkproduct streamlines recording, waste reconciliation, and billing for medications used in the operating room.Kit Check is used across hundreds of hospitals in the U.S. and Canada and tracks over 90% of all kit medication volume in the industry that is digitally tracked. | $20.4M / Series C / Jun 20, 2016 | |
Bluesight
|
Bluesight solves supply chain inefficiencies and reduces risk by providing actionable analytics for every step of the medication lifecycle. Through our suite of Medication Intelligence™ solutions, Bluesight brings simplicity, visibility, and predictability to the complex world of medication management .To date, more than a 1000 U.S. and Canadianhospitals utilize Bluesight solutions to optimize their hospital’s efficiency. Bluesight focuses on providing comprehensive, item- level data that empowers providers to make informed, accurate decisions. These solutions include RFID-enabled inventory management, controlled substance diversion prevention software and medication purchasing optimization. | Series C / Jun 20, 2016 | |
Opsonix
|
Opsonix is developing and commercializing a pathogen-extracting therapy that uses its proprietary pathogen-capture proteins to remove infectious microbes and the toxins they release from circulating blood, offering a new broad-spectrum approach to transform the treatment of blood-borne infectious diseases, including sepsis. | $8M / Series A / Oct 08, 2015 | |
| See all 19 investments → | |||
Co-Investors
Andera Partners
3 deals together
Black Granite Capital
2 deals together
Circuit Health
2 deals together
Easton Capital
2 deals together
Kaiser Permanente Ventures
2 deals together
Kleiner Perkins
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Baxter Ventures invest in?
Baxter Ventures invests primarily in Health Care, Biotechnology and Therapeutics startups, most often at Series C and Series A stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Baxter Ventures?
Public channels for Baxter Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Baxter Ventures?
The team at Baxter Ventures includes Anne Sissel (Vice President, Strategic Initiatives Advanced Surgery). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
